Ardea Outcomes’ poster presented at ISOQOL 2020 demonstrates the validity and responsiveness of Goal Attainment in dementia and Alzheimer disease drug trials.

Justin Stanley; Sanja Stanojevic, Chere Chapman, Kari Knox, Taylor Dunn, Susan Howlett, Kenneth Rockwood (October 2020); Individualized Goal Attainment Scaling as a patient-reported outcome measure for Alzheimer disease and dementia.